XBiotech Inc.
NASDAQ:XBITBiotechnology
Healthcare
$1.68 -0.84%
-$0.02 today
- Market cap
- $51.22M
- Beta
- 0.84
- P/E (TTM)
- -1.8
- EPS (TTM)
- -$1.32
52W Low $2.09High $3.61
Volume 0.05M
Average 0.03M
Balance Sheet
Inspect the capital base behind the business.
Assets
$150.08M
FY 2025 · Annual
-24.6% YoYLiabilities
$9.73M
FY 2025 · Annual
-42.2% YoYEquity
$140.35M
FY 2025 · Annual
-23.0% YoYBalance Sheet
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 236.98M | 157.31M | 200.02M | 172.68M | 125.55M |
| Short-term Investments | 0 | 60.17M | 0 | 0 | 0 |
| Net Receivables | 8.95M | 1.76M | 935K | 858K | 360K |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 601K | 760K | 1.03M | 1.04M |
| Total Current Assets | 246.87M | 219.84M | 201.72M | 174.57M | 126.95M |
| Property, Plant & Equipment (Net) | 28.31M | 26.26M | 24.9M | 24.53M | 23.13M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 1.09M | 1.66M | 0 | 0 | 0 |
| Other Non-current Assets | (1.09M) | (1.66M) | 0 | 0 | 0 |
| Total Non-current Assets | 28.31M | 26.26M | 24.9M | 24.53M | 23.13M |
| Total Assets | 275.18M | 246.1M | 226.62M | 199.09M | 150.08M |
| Account Payables | 2.07M | 2.41M | 2.52M | 2.22M | 1.54M |
| Short-term Debt | 0 | 0 | 0 | 10.25M | 0 |
| Tax Payables | 10K | 55K | 83K | 1.72M | 76K |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 904K | 1.17M | 562K | 611K | 5.18M |
| Total Current Liabilities | 3.45M | 4.07M | 6.1M | 15.11M | 7.93M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 873K | 59K | 0 | 0 | 5K |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 1.47M | 1.58M | 1.67M | 1.72M | 1.8M |
| Total Non-current Liabilities | 2.34M | 1.64M | 1.67M | 1.72M | 1.8M |
| Total Liabilities | 5.79M | 5.7M | 7.77M | 16.83M | 9.73M |
| Common Stock | 262.26M | 267.33M | 271.15M | 273.11M | 276.73M |
| Retained Earnings | 5.15M | (27.75M) | (52.31M) | (90.84M) | (136.38M) |
| Accumulated OCI | 1.97M | 826K | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 269.39M | 240.4M | 218.85M | 182.27M | 140.35M |
| Total Debt | 0 | 0 | 0 | 10.25M | 0 |
| Net Debt | (236.98M) | (157.31M) | (200.02M) | (162.43M) | (125.55M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $115.5M |
| Receivables | $302.0K |
| Other Current | $1.3M |
| Total Current Assets | $117.0M |
| PP&E (Net) | $22.8M |
| Total Non-current Assets | $22.8M |
| Total Assets | $139.8M |
Analysis
Selected assets total $139.8M for Latest. The largest visible component is Cash & Equivalents at $115.5M, about 82.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 13, 2026 | |
| 10-Q | Quarterly report | Nov 12, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 28, 2026 | |
| 3 | Initial statement of beneficial ownership | Oct 28, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 28, 2026 |
How much cash does XBIT have?
XBiotech Inc. (XBIT) reported $125.55M in cash and equivalents in fiscal 2025.
How much debt does XBIT carry?
XBiotech Inc. (XBIT) reported $0.00 of total debt, with net debt of -$125.55M.
Continue the stock analysis
Jump to another research area for this company.